Patent Litigation Seminar

  • 03/18/2015
  • Hotel Woodbridge at Metropark

Registration


Registration is closed

Patent Litigation Seminar

Wednesday, March 18, 2015

Hotel Woodbridge at Metropark
120 Wood Avenue South, Iselin, NJ

(732) 494-6200

CLE:  4.0 PA, 4.5 NJ/NY (pending confirmation)

Event Fee:  $125 Corporate/Government Employee
                    
$100 Corporate/Government Employee - NJIPLA Member

                     $225 General Registration
                     $180 General Registration - NJIPLA Member

Program:

Noon – 12:45 p.m.   Luncheon

12:45 – 12:50 p.m.   Introduction

     Jon A. Chiodo - President, NJIPLA
     Johnson & Johnson (New Brunswick, NJ)

12:50 – 1:00 p.m.   Opening Remarks by the Chair

     Immac J. Thampoe
     Merck & Co., Inc. (Rahway, NJ)

1:00 – 1:45 p.m.     Will Congress and the Supreme Court End America's Lead in Health Science Technology and Sap the Strength of Our Industries?

     Hon. Paul R. Michel
     Chief Judge (Ret.) - United States Court of Appeals for the Federal Circuit

1:45 – 2:30 p.m.   The New Standard of Review:  The Supreme Court’s Decision in Teva v. Sandoz and the Return of the Fact/Law Distinction in Claim Construction

     William M. Jay
     Goodwin Procter, LLP (Washington, DC)

2:30– 3:15 p.m.   Alice Arrived and Look What Happened:  A Review of the Supreme Court’s June 2014 Decision and its Impact on Patents

     Brian M. Buroker
     Gibson Dunn & Crutcher LLP (Washington, DC)

3:15– 3:45 p.m.   BREAK

3:45 – 4:30 p.m.   The Rule Against Double Patenting in the Post-Gilead Era -- How We Got Here and What Will Happen Next

     Jeremy Lowe
     Axinn, Veltrop & Harkrider LLP (Hartford, CT)

4:30 – 5:30 p.m.   Biosimilars Litigation: What’s Happening on the Dance Floor? 

      Lisa M. Pensabene
      O’Melveny & Myers LLP (New York, NY)


© 2013 New Jersey Intellectual Property Law Association